260 related articles for article (PubMed ID: 11042172)
21. Smad3 and Smad4 cooperate with c-Jun/c-Fos to mediate TGF-beta-induced transcription.
Zhang Y; Feng XH; Derynck R
Nature; 1998 Aug; 394(6696):909-13. PubMed ID: 9732876
[TBL] [Abstract][Full Text] [Related]
22. Smad3 inhibits transforming growth factor-beta and activin signaling by competing with Smad4 for FAST-2 binding.
Nagarajan RP; Liu J; Chen Y
J Biol Chem; 1999 Oct; 274(44):31229-35. PubMed ID: 10531318
[TBL] [Abstract][Full Text] [Related]
23. Participation of Smad2, Smad3, and Smad4 in transforming growth factor beta (TGF-beta)-induced activation of Smad7. THE TGF-beta response element of the promoter requires functional Smad binding element and E-box sequences for transcriptional regulation.
Stopa M; Anhuf D; Terstegen L; Gatsios P; Gressner AM; Dooley S
J Biol Chem; 2000 Sep; 275(38):29308-17. PubMed ID: 10887185
[TBL] [Abstract][Full Text] [Related]
24. SMAD3/4-dependent transcriptional activation of the human type VII collagen gene (COL7A1) promoter by transforming growth factor beta.
Vindevoghel L; Lechleider RJ; Kon A; de Caestecker MP; Uitto J; Roberts AB; Mauviel A
Proc Natl Acad Sci U S A; 1998 Dec; 95(25):14769-74. PubMed ID: 9843964
[TBL] [Abstract][Full Text] [Related]
25. Synergistic cooperation between Sp1 and Smad3/Smad4 mediates transforming growth factor beta1 stimulation of alpha 2(I)-collagen (COL1A2) transcription.
Zhang W; Ou J; Inagaki Y; Greenwel P; Ramirez F
J Biol Chem; 2000 Dec; 275(50):39237-45. PubMed ID: 11007770
[TBL] [Abstract][Full Text] [Related]
26. TGFbeta and BMP-2 activation of the OPN promoter: roles of smad- and hox-binding elements.
Hullinger TG; Pan Q; Viswanathan HL; Somerman MJ
Exp Cell Res; 2001 Jan; 262(1):69-74. PubMed ID: 11120606
[TBL] [Abstract][Full Text] [Related]
27. Direct interaction of Ski with either Smad3 or Smad4 is necessary and sufficient for Ski-mediated repression of transforming growth factor-beta signaling.
Ueki N; Hayman MJ
J Biol Chem; 2003 Aug; 278(35):32489-92. PubMed ID: 12857746
[TBL] [Abstract][Full Text] [Related]
28. Transforming growth factor-beta up-regulates the beta 5 integrin subunit expression via Sp1 and Smad signaling.
Lai CF; Feng X; Nishimura R; Teitelbaum SL; Avioli LV; Ross FP; Cheng SL
J Biol Chem; 2000 Nov; 275(46):36400-6. PubMed ID: 10964912
[TBL] [Abstract][Full Text] [Related]
29. The oncoprotein Ski acts as an antagonist of transforming growth factor-beta signaling by suppressing Smad2 phosphorylation.
Prunier C; Pessah M; Ferrand N; Seo SR; Howe P; Atfi A
J Biol Chem; 2003 Jul; 278(28):26249-57. PubMed ID: 12732634
[TBL] [Abstract][Full Text] [Related]
30. Transforming growth factor-beta repression of matrix metalloproteinase-1 in dermal fibroblasts involves Smad3.
Yuan W; Varga J
J Biol Chem; 2001 Oct; 276(42):38502-10. PubMed ID: 11502752
[TBL] [Abstract][Full Text] [Related]
31. The functional interaction between the paired domain transcription factor Pax8 and Smad3 is involved in transforming growth factor-beta repression of the sodium/iodide symporter gene.
Costamagna E; García B; Santisteban P
J Biol Chem; 2004 Jan; 279(5):3439-46. PubMed ID: 14623893
[TBL] [Abstract][Full Text] [Related]
32. Smad6 as a transcriptional corepressor.
Bai S; Shi X; Yang X; Cao X
J Biol Chem; 2000 Mar; 275(12):8267-70. PubMed ID: 10722652
[TBL] [Abstract][Full Text] [Related]
33. Smad proteins regulate transcriptional induction of the SM22alpha gene by TGF-beta.
Chen S; Kulik M; Lechleider RJ
Nucleic Acids Res; 2003 Feb; 31(4):1302-10. PubMed ID: 12582250
[TBL] [Abstract][Full Text] [Related]
34. Phosphorylation of Ser465 and Ser467 in the C terminus of Smad2 mediates interaction with Smad4 and is required for transforming growth factor-beta signaling.
Souchelnytskyi S; Tamaki K; Engström U; Wernstedt C; ten Dijke P; Heldin CH
J Biol Chem; 1997 Oct; 272(44):28107-15. PubMed ID: 9346966
[TBL] [Abstract][Full Text] [Related]
35. Group 13 HOX proteins interact with the MH2 domain of R-Smads and modulate Smad transcriptional activation functions independent of HOX DNA-binding capability.
Williams TM; Williams ME; Heaton JH; Gelehrter TD; Innis JW
Nucleic Acids Res; 2005; 33(14):4475-84. PubMed ID: 16087734
[TBL] [Abstract][Full Text] [Related]
36. Tenascin-C upregulation by transforming growth factor-beta in human dermal fibroblasts involves Smad3, Sp1, and Ets1.
Jinnin M; Ihn H; Asano Y; Yamane K; Trojanowska M; Tamaki K
Oncogene; 2004 Mar; 23(9):1656-67. PubMed ID: 15001984
[TBL] [Abstract][Full Text] [Related]
37. Smad2 and Smad3 positively and negatively regulate TGF beta-dependent transcription through the forkhead DNA-binding protein FAST2.
Labbé E; Silvestri C; Hoodless PA; Wrana JL; Attisano L
Mol Cell; 1998 Jul; 2(1):109-20. PubMed ID: 9702197
[TBL] [Abstract][Full Text] [Related]
38. Nuclear factor YY1 inhibits transforming growth factor beta- and bone morphogenetic protein-induced cell differentiation.
Kurisaki K; Kurisaki A; Valcourt U; Terentiev AA; Pardali K; Ten Dijke P; Heldin CH; Ericsson J; Moustakas A
Mol Cell Biol; 2003 Jul; 23(13):4494-510. PubMed ID: 12808092
[TBL] [Abstract][Full Text] [Related]
39. The androgen receptor represses transforming growth factor-beta signaling through interaction with Smad3.
Chipuk JE; Cornelius SC; Pultz NJ; Jorgensen JS; Bonham MJ; Kim SJ; Danielpour D
J Biol Chem; 2002 Jan; 277(2):1240-8. PubMed ID: 11707452
[TBL] [Abstract][Full Text] [Related]
40. TLP, a novel modulator of TGF-beta signaling, has opposite effects on Smad2- and Smad3-dependent signaling.
Felici A; Wurthner JU; Parks WT; Giam LR; Reiss M; Karpova TS; McNally JG; Roberts AB
EMBO J; 2003 Sep; 22(17):4465-77. PubMed ID: 12941698
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
